Log In
Print this Print this

BreathLink rapid point-of-care breath test for breast cancer

  Manage Alerts
Collapse Summary General Information
Company Menssana Research Inc.
DescriptionSix-minute breath test for breast cancer using volatile organic compounds in breath
Molecular Target
Mechanism of Action 
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentApproved
Standard IndicationCancer, Diagnostic
Indication DetailsIdentify patients with early stage breast cancer or an abnormal screening mammogram
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today